Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12612000385842Phase 2Recruiting
Phase 2 trial of remifentanil in procedural pain (2 arms), sponsored by Dr Susan M Lord. Primary endpoint: Pain during central venous catheter insertion. Started Jul 2009; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12612000385842.